Twist Bioscience (TWST) Competitors $32.79 +1.67 (+5.37%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$32.72 -0.06 (-0.20%) As of 07:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TWST vs. ADPT, BEAM, CRSP, NTLA, TXG, VCYT, RNA, ABVX, LEGN, and CYTKShould you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Adaptive Biotechnologies (ADPT), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Intellia Therapeutics (NTLA), 10x Genomics (TXG), Veracyte (VCYT), Avidity Biosciences (RNA), Abivax (ABVX), Legend Biotech (LEGN), and Cytokinetics (CYTK). These companies are all part of the "medical" sector. Twist Bioscience vs. Its Competitors Adaptive Biotechnologies Beam Therapeutics CRISPR Therapeutics Intellia Therapeutics 10x Genomics Veracyte Avidity Biosciences Abivax Legend Biotech Cytokinetics Twist Bioscience (NASDAQ:TWST) and Adaptive Biotechnologies (NASDAQ:ADPT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations. Is TWST or ADPT more profitable? Twist Bioscience has a net margin of -23.51% compared to Adaptive Biotechnologies' net margin of -59.07%. Twist Bioscience's return on equity of -29.03% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-23.51% -29.03% -21.77% Adaptive Biotechnologies -59.07%-60.93%-23.03% Which has stronger earnings and valuation, TWST or ADPT? Adaptive Biotechnologies has lower revenue, but higher earnings than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$312.97M6.32-$208.73M-$1.45-22.61Adaptive Biotechnologies$178.96M13.23-$159.49M-$0.82-18.96 Which has more volatility & risk, TWST or ADPT? Twist Bioscience has a beta of 2.38, indicating that its stock price is 138% more volatile than the S&P 500. Comparatively, Adaptive Biotechnologies has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. Does the media prefer TWST or ADPT? In the previous week, Twist Bioscience had 13 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 17 mentions for Twist Bioscience and 4 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 0.46 beat Twist Bioscience's score of -0.03 indicating that Adaptive Biotechnologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Adaptive Biotechnologies 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer TWST or ADPT? Twist Bioscience presently has a consensus price target of $48.50, suggesting a potential upside of 47.91%. Adaptive Biotechnologies has a consensus price target of $13.22, suggesting a potential downside of 14.97%. Given Twist Bioscience's higher probable upside, equities analysts clearly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 2 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.58Adaptive Biotechnologies 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 Do insiders & institutionals have more ownership in TWST or ADPT? 99.2% of Adaptive Biotechnologies shares are held by institutional investors. 3.0% of Twist Bioscience shares are held by insiders. Comparatively, 6.4% of Adaptive Biotechnologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryTwist Bioscience and Adaptive Biotechnologies tied by winning 8 of the 16 factors compared between the two stocks. Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TWST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TWST vs. The Competition Export to ExcelMetricTwist BioscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.88B$3.35B$6.09B$10.54BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-22.6121.5785.5527.60Price / Sales6.32271.43537.79201.45Price / CashN/A47.1237.9261.55Price / Book4.0610.1412.996.76Net Income-$208.73M-$52.31M$3.30B$275.88M7 Day Performance6.88%5.14%4.33%2.81%1 Month Performance30.69%14.68%9.48%9.24%1 Year Performance-20.89%30.98%84.61%35.42% Twist Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TWSTTwist Bioscience3.7451 of 5 stars$32.79+5.4%$48.50+47.9%-22.9%$1.88B$312.97M-22.61990Trending NewsAnalyst ForecastInsider TradeADPTAdaptive Biotechnologies3.047 of 5 stars$13.46+1.8%$12.38-8.1%+196.2%$2.01B$178.96M0.00790Analyst ForecastBEAMBeam Therapeutics2.894 of 5 stars$23.91+4.1%$46.40+94.1%+16.1%$2.32B$63.52M0.00510News CoverageAnalyst ForecastCRSPCRISPR Therapeutics1.4502 of 5 stars$63.77+3.4%$71.50+12.1%+69.9%$5.61B$37.31M0.00460Analyst ForecastNTLAIntellia Therapeutics4.1878 of 5 stars$16.92+3.7%$27.39+61.9%+36.8%$1.75B$57.88M0.00600News CoverageAnalyst UpgradeTXG10x Genomics3.7984 of 5 stars$11.34-3.2%$13.65+20.4%-40.0%$1.46B$610.78M0.001,240High Trading VolumeVCYTVeracyte3.6775 of 5 stars$33.61+0.5%$40.90+21.7%+4.8%$2.63B$445.76M36.35790Analyst UpgradeInsider TradeRNAAvidity Biosciences2.2228 of 5 stars$42.63-0.7%$68.32+60.3%+4.2%$6.27B$10.90M0.00190Analyst ForecastInsider TradeABVXAbivax2.9196 of 5 stars$83.33+0.6%$102.14+22.6%+847.5%$6.26BN/A0.0061Analyst ForecastAnalyst RevisionLEGNLegend Biotech2.5959 of 5 stars$32.85-1.6%$74.22+125.9%-33.0%$6.16B$627.24M0.002,609News CoverageAnalyst ForecastCYTKCytokinetics3.7433 of 5 stars$53.89+6.9%$75.71+40.5%+11.9%$6.03B$18.47M0.00250Trending NewsAnalyst ForecastInsider Trade Related Companies and Tools Related Companies Adaptive Biotechnologies Alternatives Beam Therapeutics Alternatives CRISPR Therapeutics Alternatives Intellia Therapeutics Alternatives 10x Genomics Alternatives Veracyte Alternatives Avidity Biosciences Alternatives Abivax Alternatives Legend Biotech Alternatives Cytokinetics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TWST) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
